Laura R. Taddei

Laura R. Taddei serves as a Contract Specialist responsible for managing the full lifecycle of procurement actions within her organization, ensuring compliance with federal acquisition regulations and promoting efficient, transparent contracting practices. She specializes in the acquisition of ophthalmic goods, overseeing solicitations, contract award, and performance monitoring for medical devices and vision care equipment. Her role is central to fulfilling mission-critical healthcare requirements through timely and legally sound contracting actions, with a focus on technical accuracy and regulatory adherence. Taddei works with a broad range of suppliers specializing in the design, manufacture, and distribution of ophthalmic products, including corrective lenses, diagnostic instruments, and surgical accessories. While no single contractor dominates her portfolio, she maintains consistent engagement with manufacturers holding relevant quality certifications such as ISO 13485 and FDA registrations. Her contracting approach emphasizes vendor reliability, technical capability, and adherence to product specifications, fostering long-term partnerships grounded in performance accountability and regulatory compliance. Taddei’s contracting activity is entirely non-set-aside, reflecting a procurement strategy prioritizing open competition and broad market access. Her approach does not favor socioeconomic programs such as 8(a), HUBZone, or SDVOSB, instead focusing on selecting the most technically qualified and cost-effective offerors regardless of business size or certification status. This reflects a mission-driven emphasis on product performance and regulatory conformity over socioeconomic targeting. Her primary procurement focus is on NAICS 339115—Ophthalmic Goods Manufacturing—where she specializes in acquiring precision optical devices, contact lenses, intraocular lenses, and diagnostic ophthalmic equipment. Taddei possesses deep technical familiarity with FDA-regulated medical devices and the unique compliance requirements of vision care products, ensuring all acquisitions meet clinical standards and safety protocols. Her expertise lies at the intersection of medical technology procurement and federal acquisition policy.